Four Founders Just Proved The Classics Still Work

Good morning, crowd. 

Four founders just proved the classics still work:

• Retention beats virality

• Healthcare beats hype

• Boring infrastructure wins wars

• Understanding people at scale is worth $50M

Here are this week's founder stories.

Read time: 4 mins

The Physical AI Boom Reaches The Farm

Most AI lives on a screen. This kind drives itself through a soybean field at 2 a.m. and cuts weeds to the centimeter, with no herbicide. has 82 machines running across 16 states. This year's fleet sold out, and every robot was delivered. 

The platform keeps adding jobs: weeding now, feeding, spraying, and cover-crop planting on the way. Farmers are done with chemicals linked to Parkinson's and tied to the price of oil. 

The pull is real, and the machines work. lets everyday investors own a stake ahead of the scale-up the company is building toward.

^{Greenfield Robotics is Testing The Waters under tier 2 of Regulation A. No money or other consideration is being solicited, and if sent in response will not be accepted. No offer to buy the securities can be accepted and no part of the purchase price can be received until the offering statement filed by the company with the SEC has been qualified by the SEC. Any such offer may be withdrawn or revoked, without obligation or commitment of any kind, at any time before notice of acceptance given after the date of qualification. An indication of interest involves no obligation or commitment of any kind. “Reserving” shares is simply an indication of interest. There is no binding commitment for investors that reserve shares in this manner to ultimately invest and purchase the shares reserved of the company, or to purchase any shares of the company whatsoever.}

FRESH NEWS

Retro

Founder's Angle: Three founders just raised $21M Series A for Retro, a photo-sharing app for friends instead of algorithmic feeds. No growth hacks. No viral loops. Just: "People want to share photos with actual friends, not strangers." That's a $21M insight.

The story:

• Retro: Photo-sharing app, subscription model ($4.99/month)

• Funding: $21M Series A (Field Ventures + Thrive Capital co-leading)

• Product: Share photos with friends, no algorithm deciding what you see

• Market insight: Algorithm fatigue is real (TikTok algorithm burnout, Instagram feed bloat)

• Founder thesis: Retention > virality (friends matter more than followers)

• Capital insight: Thrive backed this because subscription social software is rare

• Competitive advantage: Social graph of real friends = defensible, sticky product

Why it matters: When Thrive Capital backs a photo app over the 500 "TikTok killers" every founder pitches, it means: (1) retention-focused social products are fundable, (2) subscription social is the new frontier (not free + ads), (3) algorithm fatigue is creating openings for human-first experiences. Retro's $21M isn't about being the next Instagram. It's about building for the 50 million people tired of algorithmic feeds.

Founder wisdom: The classic startup playbook still works: solve one real problem (algorithm fatigue), charge for it (subscription), build retention-first (friends motif). Retro proved venture wants this. No growth hacks required.

Signalbase

Why Founders Care: NewDays just extended its seed funding to $16M (another $9M from Madrona and General Catalyst) by combining telehealth clinicians with cognitive exercises for dementia patients. Their insight: Trust the doctor, add technology, not the reverse.

The story:

• NewDays: Telehealth + cognitive exercises for dementia and cognitive impairment

• Funding: Seed extension of $9M (total $16M seed)

• Model: Clinician-led treatment + software-guided exercises

• Market: 6M+ Americans with dementia (growing category)

• Unit economics: Insurance covers treatment (not a consumer subscription play)

• Founder thesis: Healthcare is fundable when you respect clinicians, not replace them

• Capital insight: Madrona + General Catalyst backing because repeatable healthcare revenue model

Why it matters: Healthcare founders often try to "disrupt" medicine with technology. NewDays went the opposite direction: Let clinicians lead, use technology to scale their impact. When two Tier-1 VCs put $9M more into a seed round, it means: (1) healthcare software working with (not against) doctors is undervalued, (2) repeatable revenue models (insurance reimbursement) matter more than consumer virality, (3) dementia care is a trillion-dollar category with no good solutions. NewDays is building for legacy healthcare infrastructure, and that infrastructure will pay billions to get this right.

Founder wisdom: The unsexy healthcare play beats the viral social play. Why? Because insurance companies have budgets in the billions. Doctors trust clinician-led approaches. Dementia patients have zero alternatives. Build boring healthcare that works, get billions in reimbursement.

Empirik

Deal DNA: Sequoia Capital backed Empirik, a startup that maps enterprise infrastructure so engineers can predict outages before they happen. This is the "boring infrastructure" play that wins venture capital.

The story:

• Empirik: Infrastructure mapping + predictive analytics for enterprise engineers

• Funding: $21M seed (Sequoia Capital + S32 co-leading)

• Problem solving: Engineers today can't predict the impact of their changes before deploying

• Product value: Predict outages, prevent revenue loss, sleep at night

• Market size: Every company with $100M+ infrastructure budget needs this

• Unit economics: Enterprise SaaS ($100K-$500K ACV, low churn)

• Founder insight: Unsexy infrastructure problems = biggest enterprise budgets

Why it matters: When Sequoia leads a $21M seed into infrastructure automation, it means: (1) enterprise engineering problems are still venture-fundable, (2) predictability is worth more than flashiness, (3) a startup that helps engineers prevent disasters can build a $100M+ business in 3-5 years. Empirik isn't going to go viral. Empirik is going to be standard infrastructure at every Fortune 500 company within 5 years.

Founder wisdom: Venture loves unsexy problems with big budgets. Every CTO at every large company wakes up terrified of unplanned outages. Empirik charges millions to eliminate that fear. That's a durable $1B+ business.

Tech.eu

Why Founders Care: Conveo raised a $50M Series A (DST Global + Balderton leading) by automating consumer research interviews at scale. They're answering the question every marketer has: "What do consumers actually want to tell us?"

The story:

• Conveo: Video and voice interview platform for consumer research

• Funding: $50M Series A (DST Global + Balderton + Y Combinator backing)

• Problem: Market research is slow, expensive, qualitative, hard to scale

• Solution: Conduct and analyze hundreds of interviews simultaneously

• Market: Every CPG brand, every product team needs consumer feedback

• Unit economics: Enterprise research budgets ($100K-$5M+ per project)

• Founder thesis: Understand people at scale, not just run surveys

Why it matters: When DST Global (an aggressive growth investor) puts $50M into a research tools company, it means: (1) consumer research is broken and expensive (opportunity), (2) the $10B+ market research industry is ripe for disruption, (3) brands will pay millions to really understand their customers. Conveo isn't replacing researchers—it's making them 10x more efficient. That efficiency multiplier is worth $50M Series A + future $1B+ exit.

Founder wisdom: B2B software that helps Fortune 500 companies do their jobs better is boring but fundable. Conveo helps brands understand customers faster. Every brand has budget for this. Build tools for billion-dollar companies, get billion-dollar exits.

🚀 THIS WEEK'S FOUNDER SIGNALS

Retro ($21M): Subscription + retention beats virality + ads. Friend graphs matter more than follower counts. Consumer social is alive if you respect user time.

NewDays ($16M seed): Healthcare works when you respect clinicians, not replace them. Insurance reimbursement >> consumer subscriptions. Boring healthcare is fundable healthcare.

Empirik ($21M): Enterprise infrastructure problems have massive budgets. Unsexy + practical + preventative = venture-fundable. Outage prevention is worth billions.

Conveo ($50M Series A): Consumer research is broken and expensive. DST Global betting $50M that understanding people at scale is a $1B+ market. Every brand needs this.

📊 CAPITAL ALLOCATION PATTERNS

Subscription social is back: Retro proved retention-based social is fundable. The algorithm fatigue is real.

Healthcare + clinicians wins: NewDays showing that tech + doctors = repeatable, insurance-backed revenue.

Infrastructure automation > consumer virality: Empirik + Conveo combined got $71M (seed + Series A) for boring enterprise problems. Meanwhile, viral social startups get passed on.

Unsexy wins: The pattern this week: every founder who solved a real, boring, expensive problem got funded. Empirik preventing outages. Conveo understanding customers. NewDays treating dementia. Retro respecting user time.

☕ FOUNDER WISDOM FROM THIS WEEK

If you're starting something new, here's what gets funded in Sept 2026:

NOT: Another social app trying to compete with TikTok YES: A retention-focused app for real friends (proven by Retro)

NOT: AI-first healthcare disruption YES: Clinician-led care with software support (proven by NewDays)

NOT: Consumer viral loops YES: Enterprise infrastructure preventing disasters (proven by Empirik)

NOT: Survey tools YES: Understanding consumers at scale (proven by Conveo)

The thesis: Capital is tired of hype. Capital wants problems that: (1) real customers pay for, (2) solve existing industry pain, (3) scale predictably, (4) have defensible moats (network effects, switching costs, incumbency).

Retro, NewDays, Empirik, and Conveo all fit this thesis. That's why they're collectively raising $97M this week.

☕ HUNT ACCORDINGLY

If you're a founder: Build for retention, not virality. Respect your users. Solve real problems. Charge premium prices for boring solutions.

If you're an investor:

Unsexy infrastructure > viral consumer. Subscription > ads. Clinician-led > tech-first.

If you're watching the market: The classics still work.

Boring wins. Retention beats growth.

Healthcare + infrastructure + retention = the capital of September 2026.

See you soon,

Jose, Alberto, and the Founderscrowd editorial team